文献速递神经肿瘤

人类免疫缺陷病毒感染患者胶质瘤的临床特征与预后分析

Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
PubMed 文献 · World Neurosurg · 2018-03-08

该研究报道了本院2例HIV感染合并胶质瘤患者的诊疗与预后,并对HIV相关胶质瘤患者进行系统文献综述,共纳入34例。中位生存期为9个月,单因素分析显示WHO分级、手术方式和放疗与总生存显著相关,多因素分析显示WHO分级和手术方式是总生存的独立预后因素。

要点

  • HIV感染合并胶质瘤患者多数为星形细胞瘤或高级别胶质瘤,中位生存期9个月。
  • 单因素分析显示WHO分级、手术方式(切除/立体定向活检)和放疗与总生存显著相关。
  • 多因素分析显示WHO分级和手术方式是总生存的独立预后因素。

核心结论

  • 多数HIV感染合并胶质瘤患者为星形细胞瘤或高级别胶质瘤。
  • 所有HIV感染胶质瘤患者的中位生存期短于胶质母细胞瘤(GBM)患者。
  • 手术和WHO分级是总生存的独立预后因素。

研究设计与样本

  • 本研究报道了本院2例HIV感染合并胶质瘤患者的诊疗与预后,并对HIV相关胶质瘤患者进行定量、全面的系统文献综述。
  • 研究结合本院治疗经验与回顾性获取的治疗信息,分析年龄、性别、WHO分级、手术、放疗、化疗及放化疗联合能否预测患者生存。
  • 研究共纳入34例患者,包括本院2例。

主要发现

  • 全部患者的中位生存期为9个月。
  • 单因素分析显示WHO分级(低级别胶质瘤/高级别胶质瘤)、手术(手术切除/立体定向活检)和放疗与总生存显著相关。
  • 多因素分析显示WHO分级和手术是总生存的显著预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To perform a survival analysis of human immunodeficiency virus (HIV)-patients with glioma and to assess the relationship between various prognostic factors and overall survival (OS). METHODS: We reported in detail the management and prognosis of 2 HIV-infected patients with glioma in our hospital and performed a quantitative and comprehensive systematic literature review of patients with HIV-associated glioma. We combined our treatment experience with retrospectively obtained treatment information and studied the survival time to statistically analyze whether age, sex, World Health Organization (WHO) grade, surgery, radiotherapy, chemotherapy, and combined radiotherapy and chemotherapy could predict patient survival. RESULT: The study included 34 cases, including our own 2 cases. The median survival was 9 months. On survival analysis, among the aforementioned parameters, WHO grade (low-grade glioma/high-grade glioma), surgery (surgical resection/stereotactic biopsy), and radiotherapy showed a significant association with OS by univariate analysis. Multivariate analysis showed WHO grade and surgery were significant predictors of OS. CONCLUSIONS: Most patients had astrocytoma or high-grade glioma. The median survival of all HIV-infected patients with gliomas was shorter than that of GBM patients with glioblastoma multiforme. Surgery and WHO grade were independent prognostic factors for OS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wang T, Gao T, Niu X, et al. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients. World Neurosurg. 2018. PMID: 29524717. doi:10.1016/j.wneu.2018.02.168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。